M, J., R, P., T, R., & M, M. (2023). Letter: NSBB for fatty liver disease-Still a long way to go. Authors' reply. Alimentary pharmacology & therapeutics, 58(8), 848. https://doi.org/10.1111/apt.17702
Chicago Style (17th ed.) CitationM, Jachs, Paternostro R, Reiberger T, and Mandorfer M. "Letter: NSBB for Fatty Liver Disease-Still a Long Way to Go. Authors' Reply." Alimentary Pharmacology & Therapeutics 58, no. 8 (2023): 848. https://doi.org/10.1111/apt.17702.
MLA (9th ed.) CitationM, Jachs, et al. "Letter: NSBB for Fatty Liver Disease-Still a Long Way to Go. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 58, no. 8, 2023, p. 848, https://doi.org/10.1111/apt.17702.
Warning: These citations may not always be 100% accurate.